Akebia Therapeutics, Inc. (AKBA) vs Anika Therapeutics Inc. (ANIK)
- Akebia Therapeutics, Inc. AKBA 0.67 −4.29%
- Anika Therapeutics Inc. ANIK 19.98 −3.43%
Akebia Therapeutics, Inc. and Anika Therapeutics Inc. are both Drug Manufacturers Specialty & Generic companies. Anika Therapeutics Inc. is the larger, with a market value of $276.9M against $192.7M — 1.4× the size. Akebia Therapeutics, Inc. grew revenue faster over the last twelve months: 7.52% against 5.33%. Anika Therapeutics Inc. has the higher net margin (−3.14% vs −13.5%) and the lower return on invested capital (−3.24% vs 0.00%). Across the 19 metrics below, Akebia Therapeutics, Inc. leads on 10 and Anika Therapeutics Inc. on 9.
Valuation
Profitability
| Metric | AKBA | ANIK | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 79.63% | 62.16% | 53.94% |
| Operating margin | (6.90%) | (4.24%) | 0.00% |
| Net margin | (13.54%) | (3.14%) | 0.00% |
| Free cash flow margin | 18.38% | 0.47% | 0.00% |
| Return on equity | (109.38%) | (2.66%) | (0.40%) |
| Return on assets | (8.53%) | (2.04%) | (3.32%) |
| Return on invested capital | 0.00% | (3.24%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack